| Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand AD Khanolkar, V Abadji, S Lin, WAG Hill, G Taha, K Abouzid, Z Meng, ... Journal of medicinal chemistry 39 (22), 4515-4519, 1996 | 208 | 1996 |
| Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agents MA Aziz, RAT Serya, DS Lasheen, AK Abdel-Aziz, A Esmat, AM Mansour, ... Scientific reports 6 (1), 24460, 2016 | 179 | 2016 |
| Penicillin binding protein 2a: An overview and a medicinal chemistry perspective MAW Shalaby, EME Dokla, RAT Serya, KAM Abouzid European Journal of Medicinal Chemistry 199, 112312, 2020 | 161 | 2020 |
| Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase W Lang, C Qin, S Lin, AD Khanolkar, A Goutopoulos, P Fan, K Abouzid, ... Journal of medicinal chemistry 42 (5), 896-902, 1999 | 157 | 1999 |
| Synthesis of certain substituted quinoxalines as antimicrobial agents (part II) MM Badran, KAM Abouzid, MHM Hussein Archives of pharmacal research 26 (2), 107-113, 2003 | 155 | 2003 |
| Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer HM Hesham, DS Lasheen, KAM Abouzid Medicinal Research Reviews 38 (6), 2058-2109, 2018 | 153 | 2018 |
| Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase K Abouzid, S Shouman Bioorganic & Medicinal Chemistry 16 (16), 7543-7551, 2008 | 146 | 2008 |
| Design and Synthesis of New Tetrazolyl- and Carboxy-biphenylylmethyl-quinazolin-4-one Derivatives as Angiotensin II AT1 Receptor Antagonists MAH Ismail, S Barker, DA Abou El Ella, KAM Abouzid, RA Toubar, ... Journal of medicinal chemistry 49 (5), 1526-1535, 2006 | 146 | 2006 |
| Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors AH Abadi, TM Ibrahim, KM Abouzid, J Lehmann, HN Tinsley, BD Gary, ... Bioorganic & medicinal chemistry 17 (16), 5974-5982, 2009 | 141 | 2009 |
| Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer FM Elmenier, DS Lasheen, KAM Abouzid European journal of medicinal chemistry 183, 111718, 2019 | 125 | 2019 |
| Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis ZSBHJ Xin Ge, Min-Hong Pan, Lin Wang, Wei Li, Chengfei Jiang, Jun He, Khaled ... cell death and disease 9, 1128, 2018 | 112 | 2018 |
| Pyridazinone derivatives: Design, synthesis, and in vitro vasorelaxant activity K Abouzid, MA Hakeem, O Khalil, Y Maklad Bioorganic & medicinal chemistry 16 (1), 382-389, 2008 | 107 | 2008 |
| Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold MI Shahin, DA Abou El Ella, NSM Ismail, KAM Abouzid Bioorganic chemistry 56, 16-26, 2014 | 92 | 2014 |
| Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity K Abouzid, SA Bekhit Bioorganic & medicinal chemistry 16 (10), 5547-5556, 2008 | 92 | 2008 |
| Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities KAM Abouzid, GH Al-Ansary, AM El-Naggar European journal of medicinal chemistry 134, 357-365, 2017 | 85 | 2017 |
| Design and synthesis of new quinoxaline derivatives as anticancer agents and apoptotic inducers AMS El Newahie, YM Nissan, NSM Ismail, DA Abou El Ella, SM Khojah, ... Molecules 24 (6), 1175, 2019 | 82 | 2019 |
| Quinoxaline‐based scaffolds targeting tyrosine kinases and their potential anticancer activity AMS El Newahie, NSM Ismail, DA Abou El Ella, KAM Abouzid Archiv der Pharmazie 349 (5), 309-326, 2016 | 80 | 2016 |
| Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria EME Dokla, NS Abutaleb, SN Milik, D Li, K El-Baz, MAW Shalaby, ... European Journal of Medicinal Chemistry 186, 111850, 2020 | 76 | 2020 |
| Pyridazine based scaffolds as privileged structures in anti-cancer therapy MY Jaballah, RT Serya, K Abouzid Drug Research 67 (03), 138-148, 2017 | 74 | 2017 |
| Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents EZ Elrazaz, RAT Serya, NSM Ismail, DA Abou El Ella, KAM Abouzid Future Journal of Pharmaceutical Sciences 1 (2), 33-41, 2015 | 73 | 2015 |
Deena S. LasheenDepartment of Pharmaceutical Chemistry, Ain Shams UniversityVerified email at pharma.asu.edu.eg
